April 14, 2026
12pm – 1pm EDT / 5pm – 6pm BST / 6pm – 7pm CEST
Europe, US, APAC
Secure Your Space
About This Webinar
In this webinar, we will discuss how recent breakthroughs in nephrology are fundamentally shifting how we manage rare kidney diseases, moving from broad interventions to targeted molecular therapies.
Join us for a comprehensive deep dive into the evolving landscape. This session will bridge the gap between complex pathophysiology and clinical practice, exploring how new regulatory-approved therapies are redefining patient outcomes.
We will also tackle the specific hurdles of the operational strategies needed to bring next-generation treatments to market faster.
Your Key Learnings
Disease Intelligence: Comprehensive overviews of IgAN, C3G, FSGS, and PMN and the impact of breakthrough treatments.
Pathophysiological Insights: Analysis of molecular pathways driving glomerular damage and the latest diagnostic approaches.
Clinical & Pediatric Challenges: Navigating early diagnosis and long-term prognosis, with a specialized focus on the pediatric population.
The Future of Care: Exploring combination therapies, innovative clinical trial designs, and strategies for faster patient recruitment and retention.
Secure Your Space
Claudio Hegenberger MD, MBA, MSc
